These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16259158)

  • 21. Fueling innovation in medical devices (and beyond): venture capital in health care.
    Ackerly DC; Valverde AM; Diener LW; Dossary KL; Schulman KA
    Health Aff (Millwood); 2009; 28(1):w68-75. PubMed ID: 19049999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could bank loans solve Europe's biotech financing slump?
    Mitchell P
    Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276
    [No Abstract]   [Full Text] [Related]  

  • 23. 2005: biotech partners up.
    Lawrence S
    Nat Biotechnol; 2006 Feb; 24(2):126. PubMed ID: 16465145
    [No Abstract]   [Full Text] [Related]  

  • 24. [Medical devices in Germany--I].
    Becks T
    Biomed Tech (Berl); 2005 Sep; 50(9):294-300. PubMed ID: 16185039
    [No Abstract]   [Full Text] [Related]  

  • 25. Japanese firms broaden investment focus to early biotech.
    Louët S; Sipp D
    Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
    [No Abstract]   [Full Text] [Related]  

  • 26. Old financing concept gains new ground.
    Pallarito K
    Mod Healthc; 1995 Jul; 25(31):34-5. PubMed ID: 10144320
    [No Abstract]   [Full Text] [Related]  

  • 27. The German MedTech industry in 2007.
    Schmitt JM; Beeres M
    Med Device Technol; 2007; 18(7):56. PubMed ID: 18075138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotechnology round the world: focus on: Spain.
    Biotechnol J; 2008 Jan; 3(1):28-30. PubMed ID: 18200495
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel approaches to innovation in medical device manufacture.
    McKay I
    Med Device Technol; 2004 Jun; 15(5):24-6. PubMed ID: 15285484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shift toward early-stage deals favors biotechs.
    Lawrence S
    Nat Biotechnol; 2006 Jan; 24(1):6. PubMed ID: 16404377
    [No Abstract]   [Full Text] [Related]  

  • 32. Focus on: Sweden.
    Biotechnol J; 2007 May; 2(5):528-30. PubMed ID: 17479974
    [No Abstract]   [Full Text] [Related]  

  • 33. Almost in bloom.
    Marris E
    Nat Biotechnol; 2008 Apr; 26(4):471-2. PubMed ID: 18392030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of the biotechnology industry in Germany.
    Müller C
    Trends Biotechnol; 2002 Jul; 20(7):287-90. PubMed ID: 12062972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investor drought and regulatory headwinds slow device innovation.
    Russell S
    Health Aff (Millwood); 2015 Feb; 34(2):199-202. PubMed ID: 25646098
    [No Abstract]   [Full Text] [Related]  

  • 36. Tech transfer revs up.
    Lawrence S
    Nat Biotechnol; 2006 Jan; 24(1):13. PubMed ID: 16404380
    [No Abstract]   [Full Text] [Related]  

  • 37. Korean biotechs seize opportunity to list on public markets.
    Louët S
    Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042
    [No Abstract]   [Full Text] [Related]  

  • 38. The reengineering of clinical engineering.
    Shaffer MJ
    Biomed Instrum Technol; 1997; 31(2):177-8. PubMed ID: 9099445
    [No Abstract]   [Full Text] [Related]  

  • 39. Inventing the future of medicine.
    Kim Y
    IEEE Eng Med Biol Mag; 2005; 24(1):5. PubMed ID: 15709527
    [No Abstract]   [Full Text] [Related]  

  • 40. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.